Contrarian Investing Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Contrarian Investing

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: pcyhuang	9/13/2006 11:52:35 PM
	Read Replies (2) of 4080

MATK-- Martek BioSciences Martek Biosciences (MRTK @$21.40) engages in the development, manufacture, and sale of products derived from microalgae and other microbes primarily in the United States. PEG Ratio (5 yr expected): 1.48; Price/Sales (ttm): 2.66; Price/Book (mrq): 1.40; 52-Week High (13-Sep-05): 44.60; 52- Week Low (08-Sep-06)3: 20.57; Shares Short (as of 10-Aug-06): 9.01M; Short Ratio (as of 10-Aug-06): 27.2. Current Ratio (mrq): 5.26; Book Value Per Share (mrq): 15.336. Insiders' buying activities on Sept. 11 and Sept. 12 around the current price. Insiders: secform4.com Daily Chart: stockcharts.com Note that in recent years, only twice has the stock such technical configuration when both the RSI (14) and % Williams reach an oversold condition simultaneously: once in May, 06 and the second time is now. Market has a combination of our criterion in contrarian investing: value + capitualted volume.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next